Cell-based apoptosis assays in oncology drug discovery

By Drewe John   Cai Sui Xiong  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 6, 2010-06 ,pp. : 583-596

Informa Healthcare

Access to resources Recommend Favorite

Approaches to the discovery of pharmacogenomic markers in oncology: 2000–2010–2020

By Huang R Stephanie   Dolan M Eileen  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 471-474

Future Medicine

Access to resources Recommend Favorite

Synergistic Approaches to Clinical Oncology Biomarker Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-09 ,pp. : 1047-1051

Bentham Science Publishers

Access to resources Recommend Favorite

Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology

By  

Current Pharmaceutical Design, Vol. 16, Iss. 24, 2010-08 ,pp. : 2724-2736

Bentham Science Publishers

Access to resources Recommend Favorite

The Wnt-dependent signaling pathways as target in oncology drug discovery

By Janssens Nico   Janicot Michel   Perera Tim  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 263-280

Springer Publishing Company

Access to resources Recommend Favorite